Trial intelligence / Profile preview

Coenzyme Q10 for prevention of high altitude heart disease and improvement of cardiac function

ChiCTR2100053923Phase 4Recruiting

Sponsor
General Hospital of Western Theater Command of PLA
Start
Dec 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of coenzyme q10 in High altitude heart disease (HAHD) (3 arms), sponsored by General Hospital of Western Theater Command of PLA. Primary endpoints: Cardiac function evaluation, Blood routine examination and 4 more. Started Dec 2021; status: recruiting.

02

Drugs

coenzyme q10
03

Conditions

High altitude heart disease (HAHD)

Beyond the preview

Go deeper on ChiCTR2100053923.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2100053923.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call